CIBC Asset Management
VIR icon

CIBC Asset Management’s Vir Biotechnology VIR Stock Holding History

CIBC Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,006
Closed -$57.1K – 1431
2025
Q3 		$57.1K Hold
10,006
– – ﹤0.01% 1225
2025
Q2 		$50.4K Hold
10,006
– – ﹤0.01% 1205
2025
Q1 		$64.8K Sell
10,006
-126
-1% -$1.12K ﹤0.01% 1157
2024
Q4 		$74.4K Buy
+10,132
New +$79.9K ﹤0.01% 1191
2022
Q1 		– Sell
-5,206
Closed -$218K – 1599
2021
Q4 		$218K Sell
5,206
-7
-0.1% -$274 ﹤0.01% 1335
2021
Q3 		$227K Buy
5,213
+514
+11% +$22.3K ﹤0.01% 1253
2021
Q2 		$222K Hold
4,699
– – ﹤0.01% 1215
2021
Q1 		$241K Buy
+4,699
New +$253K ﹤0.01% 1111

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return